Putnam Investments’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $922M | Buy |
8,456,365
+328,347
| +4% | +$34.1M | 1.22% | 15 |
|
|
2023
Q3 | $837M | Sell |
8,128,018
-183,450
| -2% | -$19.8M | 1.27% | 15 |
|
|
2023
Q2 | $959M | Sell |
8,311,468
-763,885
| -8% | -$86.7M | 1.41% | 11 |
|
|
2023
Q1 | $966M | Buy |
9,075,353
+449,860
| +5% | +$48.6M | 1.55% | 9 |
|
|
2022
Q4 | $957M | Sell |
8,625,493
-183,691
| -2% | -$18.8M | 1.67% | 6 |
|
|
2022
Q3 | $759M | Sell |
8,809,184
-243,780
| -3% | -$21.8M | 1.44% | 10 |
|
|
2022
Q2 | $825M | Buy |
9,052,964
+485,719
| +6% | +$43.1M | 1.48% | 9 |
|
|
2022
Q1 | $703M | Buy |
8,567,245
+555,013
| +7% | +$43.8M | 1.06% | 19 |
|
|
2021
Q4 | $614M | Buy |
8,012,232
+1,863,064
| +30% | +$148M | 0.88% | 28 |
|
|
2021
Q3 | $462M | Buy |
6,149,168
+81,281
| +1% | +$6.18M | 0.72% | 36 |
|
|
2021
Q2 | $472M | Buy |
6,067,887
+1,025,108
| +20% | +$76.2M | 0.73% | 37 |
|
|
2021
Q1 | $371M | Sell |
5,042,779
-740,689
| -13% | -$54.6M | 0.62% | 47 |
|
|
2020
Q4 | $451M | Sell |
5,783,468
-1,141,501
| -16% | -$87.3M | 0.8% | 30 |
|
|
2020
Q3 | $548M | Sell |
6,924,969
-770,723
| -10% | -$60.4M | 1.08% | 20 |
|
|
2020
Q2 | $568M | Sell |
7,695,692
-740,286
| -9% | -$55.7M | 1.21% | 14 |
|
|
2020
Q1 | $619M | Buy |
8,435,978
+641,187
| +8% | +$50.4M | 1.62% | 6 |
|
|
2019
Q4 | $676M | Buy |
7,794,791
+596,425
| +8% | +$49M | 1.39% | 10 |
|
|
2019
Q3 | $578M | Buy |
7,198,366
+815,393
| +13% | +$65.3M | 1.29% | 11 |
|
|
2019
Q2 | $511M | Buy |
6,382,973
+257,625
| +4% | +$19.7M | 1.14% | 14 |
|
|
2019
Q1 | $486M | Buy |
6,125,348
+415,476
| +7% | +$31.1M | 1.13% | 15 |
|
|
2018
Q4 | $416M | Buy |
5,709,872
+591,365
| +12% | +$41.7M | 1.1% | 14 |
|
|
2018
Q3 | $346M | Sell |
5,118,507
-127,576
| -2% | -$8.13M | 0.75% | 31 |
|
|
2018
Q2 | $304M | Buy |
5,246,083
+497,984
| +10% | +$28.1M | 0.69% | 33 |
|
|
2018
Q1 | $247M | Buy |
4,748,099
+335,831
| +8% | +$18.1M | 0.57% | 42 |
|
|
2017
Q4 | $237M | Sell |
4,412,268
-557,954
| -11% | -$30.9M | 0.53% | 47 |
|
|
2017
Q3 | $304M | Sell |
4,970,222
-1,002,687
| -17% | -$60.8M | 0.7% | 33 |
|
|
2017
Q2 | $365M | Buy |
5,972,909
+10,111
| +0.2% | +$615K | 0.85% | 24 |
|
|
2017
Q1 | $362M | Buy |
5,962,798
+1,245,399
| +26% | +$75.6M | 0.85% | 23 |
|
|
2016
Q4 | $265M | Sell |
4,717,399
-80,796
| -2% | -$4.73M | 0.64% | 37 |
|
|
2016
Q3 | $286M | Buy |
4,798,195
+27,617
| +0.6% | +$1.61M | 0.69% | 34 |
|
|
2016
Q2 | $262M | Buy |
4,770,578
+272,646
| +6% | +$14.5M | 0.64% | 34 |
|
|
2016
Q1 | $227M | Sell |
4,497,932
-874,941
| -16% | -$42.9M | 0.54% | 44 |
|
|
2015
Q4 | $271M | Sell |
5,372,873
-516,864
| -9% | -$26.1M | 0.61% | 35 |
|
|
2015
Q3 | $278M | Sell |
5,889,737
-339,813
| -5% | -$18.1M | 0.62% | 32 |
|
|
2015
Q2 | $338M | Buy |
6,229,550
+39,756
| +0.6% | +$2.23M | 0.68% | 31 |
|
|
2015
Q1 | $339M | Sell |
6,189,794
-94,366
| -2% | -$5.34M | 0.68% | 26 |
|
|
2014
Q4 | $341M | Buy |
6,284,160
+823,599
| +15% | +$45.9M | 0.7% | 24 |
|
|
2014
Q3 | $309M | Sell |
5,460,561
-29,224
| -0.5% | -$1.64M | 0.65% | 31 |
|
|
2014
Q2 | $303M | Sell |
5,489,785
-620,072
| -10% | -$33.8M | 0.65% | 26 |
|
|
2014
Q1 | $331M | Sell |
6,109,857
-56,556
| -0.9% | -$2.93M | 0.75% | 23 |
|
|
2013
Q4 | $294M | Buy |
6,166,413
+699,891
| +13% | +$32M | 0.71% | 28 |
|
|
2013
Q3 | $248M | Sell |
5,466,522
-177,465
| -3% | -$8.1M | 0.66% | 32 |
|
|
2013
Q2 | $250M | Buy |
+5,643,987
| New | +$252M | 0.73% | 23 |
|
Other funds holding MRK
Putnam Investments's MRK Position: Q4 2023 in Review
Putnam Investments increased its Merck (MRK) stake by 4% in Q4 2023, buying an estimated $34.1M and bringing the position to 8,456,365 shares worth $922M. The position accounts for 1.22% of the portfolio, ranked #15.
Putnam Investments first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $966M in Q1 2023. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.
- Putnam Investments held 8,456,365 shares of Merck worth $922M as of Q4 2023.
- Putnam Investments bought 328,347 Merck shares in Q4 2023, an estimated $34.1M.
- Merck made up 1.22% of Putnam Investments's portfolio in Q4 2023, its #15 holding.
- Putnam Investments first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's Merck position peaked at $966M in Q1 2023.
- 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.